Navigation auf zora.uzh.ch
Zweifel, Peter (1997). Comment on: F.M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation". International Journal of the Economics of Business, 4(3):277-279.
Comments on the article `How US Antirust Can Go Astray: The Brand Name Prescription Drug Litigation,' by F.M. Scherer. Discussion of the issue of patent protection; Uniform monopoly price; Summary of price differentiation between groups of consumers.
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 03 Faculty of Economics > Department of Economics |
| Dewey Decimal Classification: | 330 Economics |
| Scopus Subject Areas: | Social Sciences & Humanities > Business, Management and Accounting (miscellaneous)
Social Sciences & Humanities > Economics and Econometrics |
| Uncontrolled Keywords: | Antitrust policy, Price discrimination, Patent protection, Pharmaceutical industry |
| Scope: | Discipline-based scholarship (basic research) |
| Language: | English |
| Date: | 1997 |
| Deposited On: | 11 Feb 2008 12:21 |
| Last Modified: | 01 Apr 2025 03:38 |
| Publisher: | Taylor & Francis |
| ISSN: | 1357-1516 |
| OA Status: | Closed |
| Publisher DOI: | https://doi.org/10.1080/758523209 |
| Related URLs: | http://search.ebscohost.com/login.aspx?direct=true&db=buh&AN=9711264790&loginpage=Login.asp&site=ehost-live |
| Other Identification Number: | merlin-id:2059 |
Zweifel, Peter